Conference Coverage

High efficacy, no safety signals for herpes zoster vaccine post-HSCT

Publish date: March 7, 2018

 

REPORTING FROM THE 2018 BMT TANDEM MEETINGS

SOURCE: de la Serna J et al. 2018 BMT Tandem Meetings, Abstract LBA2.

Pages

Recommended Reading

Phase III trial: VZV protects auto-HCT patients
MDedge Infectious Disease
FDA panel backs licensure for epoetin alfa biosimilar
MDedge Infectious Disease
Gene therapy moves from promise to reality
MDedge Infectious Disease